Company News For Jan 2, 2020

• Shares of Neovasc Inc. soared nearly 37% after the company announced that it had submitted a premarket approval application to the U.S. Food and Drug Administration for Neovasc Reducer, used in treatment of refractory angina
• Shares of Viveve Medical, Inc. (VIVE - Free Report) jumped 46.5% after the company announced that it has regained compliance with Nasdaq listing rules
• Shares of Seadrill Limited (SDRL - Free Report) rose 7.2% after the company reported that it has received a 3-year contract for AOD II and AOD III, which is expected to be $98 million and $101 million in value
• Shares of Urovant Sciences Ltd. rose 18.4% after the company reported submission of New Drug Application for Vibegron, used for the treatment of overactive bladder

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>